Latest thinking

 

Latest thinking

Brexit FAQ: Taxation and Customs

27 March 2017

Life sciences companies with operations in the UK or Europe are wondering where to even start when it comes to Brexit-related legal issues. To give you a jumpstart, our colleagues from different practice groups across multiple countries have prepared a series of questions you should ask to better understand how Brexit will impact your business and to clarify what steps need to be taken. In this edition, we discuss questions related to taxation and customs.

Read the full article here

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom

Latest thinking - Macro

The Hogan Lovells Brexometer

22 March 2017

The Hogan Lovells Brexometer survey, in conjunction with Oxford Economics, measures the sentiment of business leaders across the world on the impact of Brexit. 

Read more

Latest thinking

Brexit FAQ: Regulation of medicinal products

13 March 2017

Life sciences companies with operations in the UK or Europe are wondering where to even start when it comes to Brexit-related legal issues. To give you a jumpstart, our colleagues from different practice groups across multiple countries have prepared a series of questions you should ask to better understand how Brexit will impact your business and to clarify what steps need to be taken. In this edition, we discuss questions related to the regulation of medicinal products.

Read the full article here

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom

Latest thinking

Brexit FAQ: Regulation of medical devices

27 February 2017

Life sciences companies with operations in the UK or Europe are wondering where to even start when it comes to Brexit-related legal issues. To give you a jumpstart, our colleagues from different practice groups across multiple countries have prepared a series of questions you should ask to better understand how Brexit will impact your business and to clarify what steps need to be taken. In this edition, we discuss questions related to the regulation of medical devices.

Read the full article here

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom

Latest thinking - Macro

EU’s Third Country Regimes and Alternatives to Passporting

23 January 2017

Hogan Lovells has collaborated with TheCityUK and The City of London Corporation's co-sponsored International Regulatory Strategy Group (IRSG), to launch a new report looking at the options for Financial Institutions in the EU's Third Country Regimes and Passporting.

Read more

Industries: Financial Institutions, Insurance
Jurisdictions: United Kingdom
Services: Financial Services, Insurance